- Title:
- Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)
- Authors:
- Source:
- In Multiple Sclerosis and Related Disorders April 2019 29:7-14
Academic Journal